Literature DB >> 26926170

Verticine, ebeiedine and suchengbeisine isolated from the bulbs of Fritillaria thunbergii Miq. inhibited the gene expression and production of MUC5AC mucin from human airway epithelial cells.

Eun Jin Kim1, Yong Pill Yoon2, Kyeong Wan Woo3, Jang-Hyun Kim1, Sang Yeon Min1, Hyun Jae Lee2, Sang Kook Lee4, Jang-Hee Hong2, Kang Ro Lee5, Choong Jae Lee6.   

Abstract

BACKGROUND: The bulb of Fritillaria thunbergii has been utilised as mucoregulators and expectorants for controlling the airway inflammatory diseases in folk medicine. HYPOTHESIS/
PURPOSE: We investigated whether verticine, ebeiedine and suchengbeisine isolated from the bulbs of Fritillaria thunbergii inhibit the gene expression and production of MUC5AC mucin from human airway epithelial cells. STUDY
DESIGN: Confluent NCI-H292 cells were pretreated with verticine, ebeiedine or suchengbeisine for 30 min and then stimulated with EGF, PMA or TNF-α for 24h. The MUC5AC mucin gene expression was measured by RT-PCR. Production of MUC5AC mucin protein was measured by ELISA.
RESULTS: (1) Verticine, ebeiedine or suchengbeisine inhibited the expression of MUC5AC mucin gene induced by EGF, PMA or TNF-α; (2) The production of MUC5AC mucin protein induced by EGF, PMA or TNF-α were also inhibited by treatment of verticine, ebeiedine or suchengbeisine.
CONCLUSION: These results suggest that verticine, ebeiedine and suchengbeisine isolated from the bulbs of Fritillaria thunbergii inhibit the gene expression and production of MUC5AC mucin, by directly acting on airway epithelial cells, and the results are consistent with the traditional use of Fritillaria thunbergii as remedy for diverse inflammatory pulmonary diseases.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Airway; Ebeiedine; Mucin; Suchengbeisine; Verticine

Mesh:

Substances:

Year:  2016        PMID: 26926170     DOI: 10.1016/j.phymed.2015.12.016

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  8 in total

Review 1.  Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses.

Authors:  Ye Wang; Hongping Hou; Qiang Ren; Haoyu Hu; Tiechui Yang; Xiwen Li
Journal:  Chin Med       Date:  2021-05-31       Impact factor: 5.455

2.  Peimine Inhibits the Production of Proinflammatory Cytokines Through Regulation of the Phosphorylation of NF-κB and MAPKs in HMC-1 Cells.

Authors:  Ji Hye Park; Bina Lee; Hyun Kab Kim; Eun-Young Kim; Jae-Hyun Kim; Ju-Hee Min; Sunkook Kim; Youngjoo Sohn; Hyuk-Sang Jung
Journal:  Pharmacogn Mag       Date:  2017-07-11       Impact factor: 1.085

Review 3.  Recent Advances in the Development of Novel Drug Candidates for Regulating the Secretion of Pulmonary Mucus.

Authors:  Xin Li; Fengri Jin; Hyun Jae Lee; Choong Jae Lee
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634

4.  Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study.

Authors:  Chia-Ling Li; Te-Chun Hsia; Chia-Hsiang Li; Ko-Jung Chen; Yao-Hsu Yang; Su-Tso Yang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

5.  Tussilagone suppressed the production and gene expression of MUC5AC mucin via regulating nuclear factor-kappa B signaling pathway in airway epithelial cells.

Authors:  Byung-Soo Choi; Yu-Jin Kim; Yong Pill Yoon; Hyun Jae Lee; Choong Jae Lee
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

6.  Water Extract of Fritillariae thunbergii Bulbus Inhibits RANKL-Mediated Osteoclastogenesis and Ovariectomy-Induced Trabecular Bone Loss.

Authors:  Ki-Shuk Shim; Dong-Ryun Gu; Youn-Hwan Hwang; Hyun Yang; Jin-Ah Ryuk; Hyunil Ha
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

Review 7.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

8.  Identifying Active Compounds and Targets of Fritillariae thunbergii against Influenza-Associated Inflammation by Network Pharmacology Analysis and Molecular Docking.

Authors:  Minjee Kim; Ki Hoon Park; Young Bong Kim
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.